This isn’t just a “play.” Brilicidin is going to be tested for possible treatment of maladies from Covid 19 in one of the 12 Regional Biolabs, possibly Boston University. Ipix signed a Material Transfer Agreement for Brilicidin. There’s a good chance we’ll hear of some results in the next few weeks. According to today’s release, IPIX expects to sign another MTA with a different virology labs. The people doing the testing must have some notion that there’s a chance for success.
People flipping for pennies here now will be coming back! IMHO!
Market Data 
Markets 
AI
